ハナフサ ノリオ   HANAFUSA, Norio
  花房 規男
   所属   医学部 医学科(東京女子医科大学病院)
   職種   教授
論文種別 原著
言語種別 英語
査読の有無 査読なし
表題 Granulocyte and monocyte apheresis therapy for patients with active ulcerative colitis associated with COVID-19: a case report
掲載誌名 正式名:Intestinal research
略  称:Intest Res
ISSNコード:15989100/15989100
掲載区分国外
巻・号・頁 20(1),pp.150-155
著者・共著者 KOROKU Miki, OMORI Teppei*, KAMBAYASHI Harutaka, MURASUGI Shun, KURIYAMA Tomoko, IKARASHI Yuichi, YONEZAWA Maria, ARIMURA Ken, KARASAWA Kazunori, HANAFUSA, Norio, KAWANA Masatoshi, TOKUSHIGE Katsutoshi
発行年月 2022/01
概要 Coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is now a pandemic. Although several treatment guidelines have been proposed for patients who have both inflammatory bowel disease and COVID-19, immunosuppressive therapy is essentially not recommended, and the treatment options are limited. Even in the COVID-19 pandemic, adjuvant adsorptive granulocyte and monocyte apheresis may safely bring ulcerative colitis (UC) into remission by removing activated myeloid cells without the use of immunosuppressive therapy. Our patient was a 25-year-old Japanese male with UC and COVID-19. This is the first case report of the induction of UC remission with granulocyte and monocyte apheresis treatment for active UC associated with COVID-19.
DOI 10.5217/ir.2020.00148
PMID 33902268